Firefly Neuroscience (AIFF) Stock Price, News & Analysis

Company Overview

Firefly Neuroscience, Inc. is a medical technology company focused on advancing brain health through objective digital biomarkers and remote monitoring solutions. Its flagship offering, the Firefly Brain Health Platform, combines portable electroencephalography (EEG) hardware, cloud-based signal processing and gamified cognitive assessments to enable early detection and ongoing tracking of neurological conditions. The company’s solutions are designed to provide clinicians, researchers and life sciences organizations with more sensitive and scalable tools for evaluating brain function outside of traditional lab settings.

At the heart of Firefly’s platform is a lightweight, user-friendly EEG headset that captures high-resolution brain signals during standardized cognitive tasks. Proprietary algorithms then analyze the data to generate quantitative metrics related to attention, memory, processing speed and neural connectivity. These digital biomarkers can be deployed in clinical trials to support endpoint assessments, as well as in outpatient and at-home environments to monitor treatment response, disease progression and recovery following injury or surgery.

Since its founding in 2017, Firefly Neuroscience has built partnerships with leading academic medical centers and pharmaceutical companies to validate its technology across a range of indications, including Alzheimer’s disease, Parkinson’s disease and traumatic brain injury. The company is headquartered in Austin, Texas, with research and business development offices in the United States and Europe. Its platform is currently undergoing regulatory and clinical evaluations in multiple geographies, and pilot programs are underway with healthcare providers seeking more cost-effective, patient-centric approaches to neurological care.

The executive leadership team comprises seasoned entrepreneurs, neuroscientists and regulatory experts, led by founder and CEO Dr. Elaine K. Bearer, a neuroscientist with decades of research experience in neuroimaging. Firefly’s management brings together technical expertise in hardware design, software engineering and clinical operations, positioning the company to address growing demand for objective, data-driven solutions in brain health and digital neurology.

Key Stats

• Today's Range: $2.75 to $2.95
• 50-Day Range: $2.74 to $3.48
• 52-Week Range: $1.86 to $17.20
• Volume: 603,076 shs
• Average Volume: 4.80 million shs
• Market Capitalization: $37.80 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AIFF Stock Analysis - Frequently Asked Questions

How have AIFF shares performed this year?

Firefly Neuroscience's stock was trading at $2.65 at the beginning of 2025. Since then, AIFF shares have increased by 9.1% and is now trading at $2.89.

How were Firefly Neuroscience's earnings last quarter?

Firefly Neuroscience, Inc. (NASDAQ:AIFF) issued its quarterly earnings results on Wednesday, May, 14th. The company reported ($1.30) EPS for the quarter. Firefly Neuroscience had a negative net margin of 1,052.34% and a negative trailing twelve-month return on equity of 954.56%.

When did Firefly Neuroscience's stock split?

Firefly Neuroscience's stock reverse split on the morning of Tuesday, August 13th 2024.The 1-3 reverse split was announced on Friday, August 9th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, August 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split.

How do I buy shares of Firefly Neuroscience?

Shares of AIFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Firefly Neuroscience own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Firefly Neuroscience investors own include Broadcom (AVGO), Paylocity (PCTY), Analog Devices (ADI), Advanced Micro Devices (AMD), ASML (ASML), Baidu (BIDU) and Bruker (BRKR).

Company Calendar

• Last Earnings: 5/14/2025
• Today: 7/16/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: Technology Services
• Sub-Industry: Computer Software
• Current Symbol: NASDAQ:AIFF
• Previous Symbol: NASDAQ:AIFF
• CIK: 803578
• Web: fireflyneuro.com
• Phone: (888) 237-6412
• Fax: 703-293-7979
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($2.94)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$10.46 million
• Net Margins: -1,052.34%
• Pretax Margin: -1,095.23%
• Return on Equity: -954.56%
• Return on Assets: -334.48%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.45
• Quick Ratio: 1.45

Sales & Book Value

• Annual Sales: $110 thousand
• Price / Sales: 337.87
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.05) per share
• Price / Book: -57.80

Miscellaneous

• Outstanding Shares: 12,860,000
• Free Float: 11,777,000
• Market Cap: $37.17 million
• Optionable: N/A
• Beta: 3.10